Ulcerative Colitis Epidemiology Analysis and Forecast to 2031

Ulcerative Colitis Market Report Overview

In the 8MM, there were 1,946,428 diagnosed prevalent cases of Ulcerative Colitis (UC) in 2021. The cases are expected to achieve an AGR of less than 1% during the period 2021-2031. Of the 8MM, Canada is expected to have the highest increase in the number of diagnosed prevalent cases of UC by 2031, and Italy will have the lowest increase in the number of diagnosed prevalent cases. Any change in the diagnosed prevalent cases of UC is attributable to the changing prevalence rates and regression trend analysis in the US, France, Spain, the UK, and Japan as well as the changing population demographics in the 8MM.

Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) characterized by chronic inflammation and ulcers (sores) in the large intestine, also called the colon and rectum. The inflammation usually begins in the rectum and lower colon, but may also spread continuously to involve the entire colon.

The Ulcerative Colitis market research report provides an overview of the risk factors, comorbidities, and the global and historical epidemiological trends for UC in the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and Canada). The report also includes a 10-year epidemiology forecast for the diagnosed incident cases and diagnosed prevalent cases of UC.

Ulcerative Colitis Market Outlook, 2021-2031 (Diagnosed Prevalent Cases)

For more insights into the Ulcerative Colitis market forecast, download a free report sample

Ulcerative Colitis Market Segmentation by Age

Depending on age, the UC market can be segmented into 0-9 years, 10-19 years, 20-29 years, 30-39 years, 40-49 years, 50-59 years, 60-69 years, 70-79 years, and 80 years or above.

In 2021, for the 8MM combined, adults aged 50–59 years contributed the highest proportion of the diagnosed prevalent cases of UC, followed by the age group 60–69 years.

Ulcerative Colitis Market Analysis, by Age, 2021 (%)

For more age insights into the Ulcerative Colitis market, download a free report sample

Ulcerative Colitis Market Segmentation by Sex

Based on sex, the UC market can be segmented into men and women.

In the 8MM, the number of diagnosed prevalent cases of UC was higher in men than in women combined.

Ulcerative Colitis Market Analysis, by Sex, 2021 (%)

For more sex insights into the Ulcerative Colitis market, download a free report sample

Ulcerative Colitis Market Report Overview

Segments Covered in the Report

Ulcerative Colitis Market Age Segments Outlook (Diagnosed Prevalent Cases, 2021-2031)

• 0-9 years
• 10-19 years
• 20-29 years
• 30-39 years
• 40-49 years
• 50-59 years
• 60-69 years
• 70-79 years
• 80 years or above

Ulcerative Colitis Market Sex Segments Outlook (Diagnosed Prevalent Cases, 2021-2031)

• Men
• Women

Scope

• The diagnosed incident cases and diagnosed prevalent cases of UC are segmented by age (for all ages in 10-year age groups for ages 0–9 years up to 80 years and older), and sex. The diagnosed prevalent cases of UC are also segmented by severity (mild-moderate, moderate-severe, and severe-fulminant) and anti-tumor necrosis factor (TNF)-responsiveness (TNF-responding, and TNF-non-responding). The report also provides the proportion of diagnosed prevalent cases of UC that develop pouchitis and post-operative UC. The model associated with the report additionally provides the total prevalent cases of UC segmented by age (for all ages) and sex.
• This epidemiology forecast for UC is supported by historical data obtained from peer-reviewed articles and population-based studies. The forecast methodology was kept consistent across the 8MM to allow for a meaningful comparison of the forecast incident and prevalent cases of UC across these markets.

Reasons to Buy

The UC epidemiology series will allow you to:

• Develop business strategies by understanding the trends shaping and driving the global UC market.
• Quantify patient populations in the global UC market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the age groups that present the best opportunities for UC therapeutics in each of the markets covered.